Some studies have demonstrated that expression levels of mTOR and downstream targets eIF4E, 4EBP1, S6K1, and S6 are potential diagnostic and prognostic biomarkers for head and neck cancer. This evidence concerns the gene RPS6 and head and neck cancer.